产品名称
抗-RSV抗体，核蛋白，克隆130-12H, clone 130-12H, Chemicon®, from mouse
biological source
mouse
antibody form
purified antibody
antibody product type
primary antibodies
clone
130-12H, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
isotype
IgG2κ
shipped in
wet ice
Quality Level
Application
ELISA（1:800+）
间接免疫荧光（1:100-200+）（新鲜冷冻组织切片）
最终工作稀释度必须由最终用户确定。
间接免疫荧光（1:100-200+）（新鲜冷冻组织切片）
最终工作稀释度必须由最终用户确定。
抗RSV抗体，核蛋白，克隆130-12H检测呼吸道合胞病毒水平，&已发布&验证可用于ELISA&IF。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
Biochem/physiol Actions
核蛋白，42-44kD
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
General description
RSV是一种不稳定的副粘病毒，在组织培养中产生人类细胞的特征性融合-合胞体效应。已经鉴定出两种亚型A和B。亚型B的特征是该病毒的无症状株。更严重的临床疾病涉及亚型A株。
Immunogen
CH-18537
Other Notes
浓度：关于批次特定浓度请参见检验报告。
Physical form
形式：纯化
纯化。 液体形式，含0.02M PB、0.25 MNaCl（Ph 7.6）、0.1%叠氮化钠。
Preparation Note
2-8°C下储存
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.
San-Juan-Vergara, H; Sampayo-Escobar, V; Reyes, N; Cha, B; Pacheco-Lugo, L; Wong et al.
Journal of virology null
Shuai Shao et al.
NPJ vaccines, 9(1), 62-62 (2024-03-20)
Respiratory syncytial virus (RSV) is one of the most important pathogens causing respiratory tract infection in humans, especially in infants and the elderly. The identification and structural resolution of the potent neutralizing epitopes on RSV fusion (F) protein enable an
Silke M Currie et al.
Journal of immunology (Baltimore, Md. : 1950), 196(6), 2699-2710 (2016-02-14)
Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in infants, causing significant morbidity and mortality. No vaccine or specific, effective treatment is currently available. A more complete understanding of the key components of effective host response
Julien Sourimant et al.
Science advances, 8(25), eabo2236-eabo2236 (2022-06-25)
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory infections in infants and the immunocompromised, yet no efficient therapeutic exists. We have identified the AVG class of allosteric inhibitors of RSV RNA synthesis. Here, we demonstrate through biolayer
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持